Sweet's syndrome and Pneumocystis carinii pneumonia: Two sequelae of low-dose cytosine arabinoside therapy in a patient with acute myeloid leukemia

V. Chowdhary, S. Nityanand, K. N. Prasad, R. Pandey, S. Dabadghao

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Cytosine arabinoside in low dose is sometimes employed for treating acute myeloid leukaemia. We report here a case of acute myeloid leukemia, treated with low-dose cytosine arabinoside, who developed acute febrile neutrophilic dermatosis and Pneumocytsis carinii pneumonia after attainment of remission. A direct effect of cytosine arabinoside on neurophil function and an immunosuppressive potential in lower doses could be speculated.

Original languageEnglish (US)
Pages (from-to)72-73
Number of pages2
JournalEuropean Journal of Haematology
Volume65
Issue number1
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Sweet Syndrome
Pneumocystis Pneumonia
Cytarabine
Acute Myeloid Leukemia
Immunosuppressive Agents
Pneumonia
Therapeutics

Keywords

  • Low-dose cytosine arabinoside
  • Pneumocystis carinii pneumonia
  • Sweet's syndrome

ASJC Scopus subject areas

  • Hematology

Cite this

Sweet's syndrome and Pneumocystis carinii pneumonia : Two sequelae of low-dose cytosine arabinoside therapy in a patient with acute myeloid leukemia. / Chowdhary, V.; Nityanand, S.; Prasad, K. N.; Pandey, R.; Dabadghao, S.

In: European Journal of Haematology, Vol. 65, No. 1, 2000, p. 72-73.

Research output: Contribution to journalArticle

@article{83ee1257deb14649a81b5186efcc7861,
title = "Sweet's syndrome and Pneumocystis carinii pneumonia: Two sequelae of low-dose cytosine arabinoside therapy in a patient with acute myeloid leukemia",
abstract = "Cytosine arabinoside in low dose is sometimes employed for treating acute myeloid leukaemia. We report here a case of acute myeloid leukemia, treated with low-dose cytosine arabinoside, who developed acute febrile neutrophilic dermatosis and Pneumocytsis carinii pneumonia after attainment of remission. A direct effect of cytosine arabinoside on neurophil function and an immunosuppressive potential in lower doses could be speculated.",
keywords = "Low-dose cytosine arabinoside, Pneumocystis carinii pneumonia, Sweet's syndrome",
author = "V. Chowdhary and S. Nityanand and Prasad, {K. N.} and R. Pandey and S. Dabadghao",
year = "2000",
doi = "10.1034/j.1600-0609.2000.9C177.x",
language = "English (US)",
volume = "65",
pages = "72--73",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Sweet's syndrome and Pneumocystis carinii pneumonia

T2 - Two sequelae of low-dose cytosine arabinoside therapy in a patient with acute myeloid leukemia

AU - Chowdhary, V.

AU - Nityanand, S.

AU - Prasad, K. N.

AU - Pandey, R.

AU - Dabadghao, S.

PY - 2000

Y1 - 2000

N2 - Cytosine arabinoside in low dose is sometimes employed for treating acute myeloid leukaemia. We report here a case of acute myeloid leukemia, treated with low-dose cytosine arabinoside, who developed acute febrile neutrophilic dermatosis and Pneumocytsis carinii pneumonia after attainment of remission. A direct effect of cytosine arabinoside on neurophil function and an immunosuppressive potential in lower doses could be speculated.

AB - Cytosine arabinoside in low dose is sometimes employed for treating acute myeloid leukaemia. We report here a case of acute myeloid leukemia, treated with low-dose cytosine arabinoside, who developed acute febrile neutrophilic dermatosis and Pneumocytsis carinii pneumonia after attainment of remission. A direct effect of cytosine arabinoside on neurophil function and an immunosuppressive potential in lower doses could be speculated.

KW - Low-dose cytosine arabinoside

KW - Pneumocystis carinii pneumonia

KW - Sweet's syndrome

UR - http://www.scopus.com/inward/record.url?scp=0033947219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033947219&partnerID=8YFLogxK

U2 - 10.1034/j.1600-0609.2000.9C177.x

DO - 10.1034/j.1600-0609.2000.9C177.x

M3 - Article

C2 - 10914942

AN - SCOPUS:0033947219

VL - 65

SP - 72

EP - 73

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 1

ER -